首页 | 本学科首页   官方微博 | 高级检索  
检索        


Patients with 10q22.3q23.1 recurrent deletion syndrome are at risk for juvenile polyposis
Institution:1. INSERM, ICM Research Center, UMRS 975, Paris, France;2. Institut du Cerveau et de la Moëlle épinière, Paris, France;3. University Hospital Dupuytren, Limoges, France;4. University Paris 6, Faculté de Médecine Pitié-Salpêtrière, Paris, France;5. AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurology, Paris, France;6. AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurophysiology, Paris, France
Abstract:Juvenile polyposis syndrome (JPS) is a rare autosomal dominant predisposition to hamartomatous polyps within the gastrointestinal tract, at high risk for malignant transformation. BMPR1A and SMAD4 loss-of-function variants account for 50% of the cases. More specifically, point mutations and structural abnormalities in BMPR1A lead to a highly penetrant yet variable phenotype of JPS. Intriguingly, in the developmental disorder caused by a recurrent 10q22.3q23.1 7 Mb deletion which includes BMPR1A, juvenile polyps have never been reported. We present the case of a young adult harboring this recurrent deletion, in a context of intellectual disability, ventricular septal defect and severe juvenile polyposis syndrome diagnosed at the age of 25 years, requiring a surgical preventive colectomy. She developed a gastric adenocarcinoma from which she died at the age of 32. We hypothesize that with the current available pangenomic CNV arrays, the diagnosis of 10q22.3q23.1 deletion is often made several years before the onset of the digestive phenotype, which could explain the absence of reports for juvenile polyps. This observation highlights the importance of an active digestive surveillance of patients with 10q22.3q23.1 deletion.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号